Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Phase 2
Completed
- Conditions
- Ocular HypertensionElevated Intraocular PressurePrimary Open Angle Glaucoma
- Interventions
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2014-09-30
- Lead Sponsor
- Alleanza Pharmaceuticals, Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT01896180
© Copyright 2025. All Rights Reserved by MedPath